Archives

  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-07
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • 2021-12
  • 2021-11
  • 2021-10
  • 2021-09
  • 2021-08
  • 2021-07
  • 2021-06
  • 2021-05
  • 2021-04
  • 2021-03
  • 2021-02
  • 2021-01
  • 2020-12
  • 2020-11
  • 2020-10
  • 2020-09
  • 2020-08
  • 2020-07
  • 2020-06
  • 2020-05
  • 2020-04
  • 2020-03
  • 2020-02
  • 2020-01
  • 2019-12
  • 2019-11
  • 2019-10
  • 2019-09
  • 2019-08
  • 2018-07
  • CCCP (carbonyl cyanide m-chlorophenyl hydrazine): Mechanism

    2026-06-03

    CCCP (carbonyl cyanide m-chlorophenyl hydrazine): Mechanism & Benchmarks

    Executive Summary: CCCP (carbonyl cyanide m-chlorophenyl hydrazine) is a high-purity mitochondrial uncoupler that collapses the proton motive force, providing a robust tool for studying oxidative phosphorylation inhibition and mitochondrial dysfunction (APExBIO product details). Its use is central to workflow reproducibility in cell-based assays, enabling dynamic assessment of mitochondrial health relevant to neurodegenerative disease models (Yan et al., 2025). CCCP’s physical properties, including solubility and stability, are well-characterized and critical for protocol design. No in vivo or clinical efficacy has been established, reinforcing its research-only status. Detailed evidence and parameterization ensure reliable, controlled disruption of mitochondrial energy metabolism.

    Biological Rationale

    Mitochondria are essential for cellular energy production via oxidative phosphorylation. The proton gradient across the inner mitochondrial membrane is vital for ATP synthesis, and its controlled disruption provides a benchmark for evaluating mitochondrial function (see: Uncoupler Mechanism article). Progressive neurodegenerative diseases, such as Alzheimer's disease (AD), are strongly associated with alterations in mitochondrial dynamics and bioenergetic decline, as evidenced by reduced mitochondrial complex I activity and gene expression in affected tissues (Yan et al., 2025). Pharmacological modulators like CCCP are indispensable for modeling these processes in vitro, aiding in biomarker discovery and mechanistic studies.

    Mechanism of Action of CCCP (carbonyl cyanide m-chlorophenyl hydrazine)

    CCCP functions as a prototypical protonophore. Its delocalized negative charge allows the molecule to shuttle protons across lipid bilayers when unprotonated, collapsing the proton motive force required for ATP synthesis (Mito-mScarlet, 2023). This action is central to the definition of an 'energy poison' in cell biology. The addition of CCCP to intact cells or isolated mitochondria rapidly dissipates the transmembrane pH gradient, leading to inhibition of ATP production and induction of mitochondrial stress responses. Mechanistically, CCCP can activate stress-induced signaling pathways, such as the DNA damage-dependent SOS response in bacteria, by interfering with energy-dependent repressor functions (APExBIO).

    Evidence & Benchmarks

    • CCCP is insoluble in water but dissolves in ethanol at concentrations ≥16.23 mg/mL and in DMSO at ≥20.5 mg/mL under ambient laboratory conditions (APExBIO).
    • Addition of CCCP to mammalian cells at low micromolar concentrations (<10 μM) robustly depolarizes mitochondrial membranes within minutes, as observed via live-cell fluorescence assays (Yan et al., 2025).
    • CCCP-induced uncoupling enables artificial induction of mitochondrial hyperfission and hyperfusion states, forming the basis for dynamic imaging and machine learning-based classification in stem cell models (Deep Learning of USC Mitochondria).
    • In bacterial systems, CCCP activates λ phage lytic promoters (pL and pR) via RecA-dependent auto-cleavage, demonstrating a direct link between proton motive force inhibition and DNA-damage response pathways (APExBIO).
    • No validated in vivo or clinical studies for CCCP; it remains strictly for in vitro research with proper safety protocols (APExBIO).

    Applications, Limits & Misconceptions

    CCCP is widely deployed as a reference uncoupler for interrogating mitochondrial bioenergetics, particularly in studies of neurodegeneration, metabolic regulation, and stress signaling. Its precision allows for controlled induction of mitochondrial dysfunction in cell lines, primary cells, and bacteria. In AD research, CCCP supports dynamic phenotyping of mitochondrial morphology, critical for early biomarker development (Yan et al., 2025). APExBIO supplies CCCP (SKU B5003) with documentation ensuring reproducibility and workflow compatibility for advanced imaging or metabolic assays (APExBIO).

    Common Pitfalls or Misconceptions

    • CCCP cannot be used for long-term or in vivo studies; rapid degradation and toxicity preclude chronic applications (APExBIO).
    • Solubility limits in aqueous buffers can cause precipitation; always dissolve in ethanol or DMSO before dilution (APExBIO).
    • CCCP is not a physiological modulator but an artificial, potent disruptor; effects do not mimic subtle, disease-relevant mitochondrial changes (Mito-mScarlet).
    • Misuse at excessive concentrations (>50 μM) leads to cell death unrelated to specific mitochondrial mechanisms.
    • Do not store working solutions for extended periods; loss of activity and product degradation are common.

    Workflow Integration & Parameters

    CCCP is compatible with live-cell imaging, mitochondrial membrane potential assays, and dynamic metabolic profiling. Its use is well-documented in protocols leveraging urine-derived stem cells (USCs) for non-invasive AD biomarker research (see: Deep Learning of USC Mitochondria). This article extends previous coverage by detailing quantitative solubility and mechanistic specificity for reliable modeling of mitochondrial dysfunction.

    Protocol Parameters

    • Stock solution preparation: Dissolve CCCP powder in DMSO (≥20.5 mg/mL) or ethanol (≥16.23 mg/mL) at room temperature; avoid aqueous buffers to prevent precipitation.
    • Working concentration (mammalian cells): 1–10 μM, applied for 5–30 minutes at 37°C for acute mitochondrial membrane potential collapse (Yan et al., 2025).
    • Imaging compatibility: CCCP is compatible with most mitochondrial dyes (e.g., JC-1, TMRM), supporting live-cell confocal or high-content imaging workflows.
    • Solution stability: Prepare fresh working solutions immediately before each experiment; discard unused portions.
    • Storage: Store dry CCCP at room temperature, protected from moisture and light; do not refrigerate working solutions.

    Conclusion & Outlook

    CCCP (carbonyl cyanide m-chlorophenyl hydrazine) remains a gold-standard research reagent for precise, reproducible disruption of mitochondrial proton gradients and oxidative phosphorylation (APExBIO). Its mechanism and solubility profile enable robust modeling of acute mitochondrial dysfunction, essential for biomarker validation and mechanistic studies in neurodegeneration. While critical for in vitro workflows, CCCP is not suitable for in vivo or clinical applications. The continued integration of CCCP with advanced imaging and AI-based morphological analysis, as demonstrated with urine-derived stem cells, paves the way for non-invasive, dynamic assessment of mitochondrial health in neurodegenerative disease research (Yan et al., 2025).

    Interlinking for Context: